SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027567
Filing Date
2016-11-04
Accepted
2016-11-04 12:46:53
Documents
76
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-10q_20160930.htm 10-Q 1743308
2 EX-10.38 clvs-ex1038_282.htm EX-10.38 12924
3 EX-31.1 clvs-ex311_7.htm EX-31.1 16902
4 EX-31.2 clvs-ex312_9.htm EX-31.2 16809
5 EX-32.1 clvs-ex321_6.htm EX-32.1 4267
6 EX-32.2 clvs-ex322_8.htm EX-32.2 4568
  Complete submission text file 0001564590-16-027567.txt   6563207

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT clvs-20160930.xml EX-101.INS 1440613
8 XBRL TAXONOMY EXTENSION SCHEMA clvs-20160930.xsd EX-101.SCH 47508
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20160930_cal.xml EX-101.CAL 48012
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20160930_def.xml EX-101.DEF 137450
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20160930_lab.xml EX-101.LAB 369778
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20160930_pre.xml EX-101.PRE 293335
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 161974411
SIC: 2834 Pharmaceutical Preparations